Amphastar Pharmaceuticals Inc. (AMPH)
NASDAQ · Healthcare
Amphastar Pharmaceuticals Inc. Net Income 2012–2025
Amphastar Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2012 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Amphastar Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was 6.4 M, a 74.61% decrease year-over-year.
- Amphastar Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was 80.1 M, a 53.11% decrease year-over-year.
- Amphastar Pharmaceuticals Inc. annual net income for 2025 was 98.1 M, a 38.51% decrease from 2024.
- Amphastar Pharmaceuticals Inc. annual net income for 2024 was 159.5 M, a 15.98% increase from 2023.
- Amphastar Pharmaceuticals Inc. annual net income for 2023 was 137.5 M, a 50.51% increase from 2022.
- Amphastar Pharmaceuticals Inc. annual net income for 2022 was 91.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Amphastar Pharmaceuticals Inc. Net Income — FAQ
Amphastar Pharmaceuticals Inc. (AMPH) net income over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Amphastar Pharmaceuticals Inc.'s net income?
Amphastar Pharmaceuticals Inc. (AMPH) reported net income of $98M for fiscal 2025.
Where can I see AMPH's net income history?
The chart and table above show Amphastar Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.